EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prolotherapy in the Treatment of Knee Osteoarthritis

F.A.C. Menegassi, J.L.R. De Faria, S.T.N. Minamoto, G.B.V. Pereira, J.P.G. Aramburú Filho, R.J.F.C. Do Amaral

Orthopaedic Journal of Sports Medicine · 2026-10 · 14 (10_suppl7)

DOI: 10.1177/2325967126s00634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Orthopaedic Journal of Sports Medicine, online erschienen am 28.10.2026. Verfasst von F.A.C. Menegassi und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the clinical outcomes of intra-articular hyaluronic acid injections and hypertonic dextrose prolotherapy (HDP) in the conservative treatment of mild to moderate knee osteoarthritis.

Methods

Ninety patients aged between 40 and 75 years were selected, all with a diagnosis of bilateral idiopathic knee osteoarthritis, classified radiographically according to the Kellgren–Lawrence classification as grade III or lower in both knees, and presenting a full range of motion (0–120°). Patients were randomized by simple randomization into three distinct groups: Group A consisted of 30 patients who received 25% HDP; Group B consisted of 30 patients who received 15% HDP; and Group C consisted of 30 patients who received intra-articular hyaluronic acid (IAHA). Patients were subsequently followed in the outpatient clinic, with pain and function assessed using the Visual Analog Scale (VAS) and questionnaires such as the Knee Society Score (KSS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at 1, 3 and 6 months.

Results

Results at the 6-month follow-up demonstrated that all three treatment protocols resulted in significant improvements in pain and function (p < 0.05); however, no statistically significant differences were observed among the groups (p > 0.52).

Conclusion

The favorable effects on pain relief and functional improvement were uniformly distributed among the treatment groups, with no measurable advantage of one protocol over another.

Zitieren

APA

Menegassi, F., Faria, J. D., Minamoto, S., Pereira, G., Filho, J. A., & Amaral, R. D. (2026). Prolotherapy in the Treatment of Knee Osteoarthritis. Orthopaedic Journal of Sports Medicine, 14(10_suppl7). https://doi.org/10.1177/2325967126s00634

Vancouver

Menegassi F, Faria JD, Minamoto S, Pereira G, Filho JA, Amaral RD. Prolotherapy in the Treatment of Knee Osteoarthritis. Orthopaedic Journal of Sports Medicine. 2026;14(10_suppl7). doi:10.1177/2325967126s00634

BibTeX
@article{Menegassi2026,
  author = {Menegassi, F.A.C. and Faria, J.L.R. De and Minamoto, S.T.N. and Pereira, G.B.V. and Filho, J.P.G. Aramburú and Amaral, R.J.F.C. Do},
  title = {Prolotherapy in the Treatment of Knee Osteoarthritis},
  journal = {Orthopaedic Journal of Sports Medicine},
  year = {2026},
  volume = {14},
  number = {10_suppl7},
  doi = {10.1177/2325967126s00634}
}
Kostenlos starten →